kanamycin a has been researched along with bergenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koul, S; Najar, MH; Nazir, N; Qurishi, MA; Zargar, MI | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for kanamycin a and bergenin
| Article | Year |
|---|---|
Evaluation of antioxidant and antimicrobial activities of Bergenin and its derivatives obtained by chemoenzymatic synthesis.
Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; Benzopyrans; Biocatalysis; Biphenyl Compounds; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Lipase; Microbial Sensitivity Tests; Molecular Conformation; Picrates; Saxifragaceae; Stereoisomerism; Structure-Activity Relationship; Xanthine Oxidase | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |